Vacuum Sealing Drainage to Help Wound Healing After Ob/Gyn Surgical Site Infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares Vacuum Sealing Drainage (VSD) with conventional wound care in patients who developed surgical site infections after obstetric or gynecologic procedures. Eligible participants have superficial, deep incisional, or organ/space SSIs where VSD is applicable and have wounds that require secondary healing or delayed closure after cleaning. The trial will monitor wound healing time, re-infection rates, hospitalization duration, and need for additional surgery to determine if VSD offers advantages over standard care. Conducted at Minia University’s advanced laparoscopy unit, the study aims to provide evidence on VSD’s role in this patient population.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Diagnosis of a surgical site infection (SSI) following an obstetric or gynecological surgical procedure (e.g., Cesarean section, hysterectomy, myomectomy, salpingo-oophorectomy).
* Wound classification as superficial incisional SSI, deep incisional SSI, or organ/space SSI (if accessible for VSD application).
* Willingness and ability to provide informed consent.
* Wound requiring secondary intention healing or delayed primary closure after debridement

Exclusion Criteria:

* Patients with necrotic tissue.
* Presence of exposed blood vessels, organs, or anastomotic sites where VSD is contraindicated.
* Untreated coagulopathy or active bleeding diathesis.
* Allergy to VSD components or dressing materials.
* Patients with significant immunosuppression (e.g., uncontrolled HIV, organ transplant recipients on high-dose immunosuppressants).
* Patients with malignant wounds.
* Patients who decline participation.
* Patients requiring immediate primary wound closure without debridement.
* Patients with a known history of severe psychiatric illness affecting compliance.

Where it's running

• Minia advanced laparoscopy unit
  Minya, Egypt Recruiting

Study contacts

• Study coordinator: Mohamed abdel ghfar
• Email: mohamedeleboany@gmail.com
• Phone: +20 10 61624335

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• PowerHeal Bioelectric Bandage for infected open wound recovery

  This tests whether the PowerHeal™ Bioelectric Bandage helps adults with infected traumatic wounds heal faster and clear infection better than standard dressings.

  Recruiting University of Pittsburgh · Ivano-Frankivsk · NCT07329114

• Antibacterial absorbable polyester dressing for chronic non-healing wounds

  This trial will test an antimicrobial absorbable polyester dressing to see if it helps adults with chronic non-healing ulcers heal faster and safely.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT07261501

• Ev.FV to heal wounds in dystrophic epidermolysis bullosa

  This trial will test whether Ev.FV, a mesenchymal stem cell-derived extracellular vesicle therapy, helps heal wounds in people with dystrophic epidermolysis bullosa.

  Recruiting Phase 1/2 Isfahan University of Medical Sciences · Isfahan · NCT07230223

• Xiang Lei ointment for healing diabetic-related ulcers

  This will test whether adding Xiang Lei ointment to standard wound care helps people with diabetic ulcers heal faster and with acceptable safety.

  Recruiting Peking University Third Hospital · Beijing, Beijing Municipality · NCT06841237

• New gel treatment for venous leg ulcers

  This study is testing a new gel treatment for people with stubborn venous leg ulcers to see if it helps them heal better than just the usual care.

  Recruiting at 5 sites Phase 3 TR Therapeutics · Jacksonville, Florida and 11 other locations · NCT06707103

• Tissue Repair Gel for treating Venous Leg Ulcers

  This study is testing a new gel to see if it helps people with stubborn leg ulcers heal better when used with standard treatment compared to standard treatment alone.

  Recruiting at 24 sites Phase 3 TR Therapeutics · Tucson, Arizona and 32 other locations · NCT06707090

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.